Business
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day
Advanced Services Business Model Driving Growth Opportunities and Recurring, High Visibility Revenue Well Positioned in Large and Growing Market Segments
About this update from Omnicell, Inc.
[{"type":"text","content":"\nAdvanced Services Business Model Driving Growth Opportunities and Recurring, High Visibility Revenue\n\nWell Positioned in Large and Growing Market Segments\n\n SANTA CLARA, Calif.--(BUSINESS WIRE)--\nOmnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management and adherence tools for health systems and pharmacies, held its 2022 Investor Day today and provided an in-depth overview of the Company’s differentiated strategy and unique business model, as well as its Advanced Services portfolio, ESG strategy, and provided more details on its long-term financial targets.\n\nRandall Lipps, Chairman, President, Chief Executive Officer, and Founder of Omnicell, said, “Thirty years ago, we set out on a mission to accelerate pharmacy to perfection, in an effort to ultimately improve medication management and patient care. Today, we are a category creator transforming the pharmacy care delivery model and delivering innovative technology that is designed to enable seamless medication management. With our track record of strong financial performance and disciplined execution, we believe Omnicell is poised to drive profitable growth and capitalize on the opportunities ahead as we continue transitioning to our Advanced Services business model.”\n\nAt today’s event, Omnicell highlighted the following:\n\n\nTransforming to Advanced Services business model and focusing on innovative solutions:\nOmnicell is focused on scaling its Advanced Services to deliver long-term value for all stakeholders and continues to drive recurring, high visibility revenue growth. As a result of this transformation, Advanced Services is expected to comprise approximately 20% to 30% of total revenue by 2025.\n\n\n\nLeading position in large and growing market segments with $90 billion+ total addressable market:\nOmnicell has solidified its position as the leading strategic partner to health systems, providing solutions across the entire continuum of care. The Company has a presence in approximately 80% of all retail pharmacies in the U.S. in addition to its long-term sole source agreements with 150 of the top 300 U.S. health systems.1\n\n\n\nDriving profitable growth through disciplined execution:\nOmnicell continues to grow and expand within its large and existing customer base, capitalize on next generation technologies, ga...